370
Views
25
CrossRef citations to date
0
Altmetric
Original Articles

Effects of nanopesticide chlorfenapyr on mice

, , , , &
Pages 1901-1907 | Received 24 Apr 2010, Accepted 28 Apr 2010, Published online: 15 Oct 2010
 

Abstract

The effects of chlorfenapyr nano preparation on mice were examined. The animals were administered with different doses of 4.84, 9.68, or 19.36 mg kg−1 of chlorfenapyr common preparation or nano preparation intraperitoneally (IP). Micronucleus (MN) test and comet assay (CA) experiments revealed that at the same dose, similar DNA damage in the peripheral blood lymphocytes of the mouse and chromosome damage in bone marrow cells of the mouse occurred with chlorfenapyr nano preparation; however, the severity of these effects was less than that found in common preparation. It is noteworthy that there were no differences in apoptotic ratio and live cell percentage in the liver cells of the mouse between these two pesticide formulations using flow cytometry. Data indicate that chlorfenapyr nanoformulation is less toxic to mouse cells than the common formulation.

Acknowledgments

This work was supported by the Natural Science and Technology Development Foundation of Shanghai (no. 053407054) and Agriculture and Science Foundation of Shanghai Jiaotong University (AE150074). We would like to thank Professor Xiuguo Hua and Dr Junfang Zhou for their assistance in experiment.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.